KWB Wealth Decreases Stock Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

KWB Wealth reduced its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 22.8% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,200 shares of the financial services provider’s stock after selling 945 shares during the quarter. KWB Wealth’s holdings in iShares Biotechnology ETF were worth $466,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in the stock. Oppenheimer Asset Management Inc. raised its stake in iShares Biotechnology ETF by 9.6% in the second quarter. Oppenheimer Asset Management Inc. now owns 24,424 shares of the financial services provider’s stock valued at $3,352,000 after buying an additional 2,141 shares during the last quarter. One Capital Management LLC purchased a new stake in iShares Biotechnology ETF in the second quarter valued at about $400,000. Edgestream Partners L.P. raised its stake in iShares Biotechnology ETF by 18.6% in the second quarter. Edgestream Partners L.P. now owns 3,772 shares of the financial services provider’s stock valued at $518,000 after buying an additional 591 shares during the last quarter. Perennial Investment Advisors LLC purchased a new stake in iShares Biotechnology ETF in the second quarter valued at about $216,000. Finally, Bradley Foster & Sargent Inc. CT raised its stake in iShares Biotechnology ETF by 4.8% in the second quarter. Bradley Foster & Sargent Inc. CT now owns 10,792 shares of the financial services provider’s stock valued at $1,481,000 after buying an additional 492 shares during the last quarter. 62.45% of the stock is currently owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Trading Down 1.8 %

iShares Biotechnology ETF stock opened at $131.57 on Wednesday. The stock has a 50-day moving average of $137.78 and a two-hundred day moving average of $141.97. iShares Biotechnology ETF has a one year low of $123.60 and a one year high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The firm also recently declared a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were paid a $0.0624 dividend. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.